- Home
- ADM vs DXCM Comparison
ADM vs DXCM Comparison
Compare ADM & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADM | DXCM |
|---|---|---|
| Founded | 1902 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.4B | 25.9B |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | ADM | DXCM |
|---|---|---|
| Price | $57.68 | $66.56 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 21 |
| Target Price | $55.67 | ★ $86.86 |
| AVG Volume (30 Days) | 2.6M | ★ 4.4M |
| Earning Date | 02-03-2026 | 02-12-2026 |
| Dividend Yield | ★ 3.55% | N/A |
| EPS Growth | N/A | ★ 7.75 |
| EPS | ★ 2.46 | 1.80 |
| Revenue | ★ $83,211,000,000.00 | $4,515,900,000.00 |
| Revenue This Year | N/A | $17.38 |
| Revenue Next Year | $4.44 | $12.76 |
| P/E Ratio | ★ $23.35 | $36.94 |
| Revenue Growth | N/A | ★ 14.21 |
| 52 Week Low | $40.98 | $54.11 |
| 52 Week High | $65.00 | $93.25 |
Technical Indicators
Market Signals| Indicator | ADM | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 42.42 | 53.62 |
| Support Level | $57.54 | $65.56 |
| Resistance Level | $58.71 | $68.18 |
| Average True Range (ATR) | 0.98 | 1.52 |
| MACD | -0.05 | -0.06 |
| Stochastic Oscillator | 10.30 | 26.91 |
Price Performance
Historical ComparisonAbout ADM Archer-Daniels-Midland Company
Archer-Daniels-Midland is a major processor of oilseeds, corn, wheat, and other agricultural commodities. The company is also one of the largest grain merchandisers through its extensive network of logistical assets to store and transport crops around the globe. ADM also runs a nutrition business that focuses on both human and animal ingredients and is a large producer of corn-based sweeteners, starches, and ethanol.
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.